|
0
|
|
Pharmacokinetic-pharmacodynamic modeling to evaluate the relative impact of immune response and meropenem on bacterial killing in vivo.
(journals.asm.org)
|
Saporta R
…
Friberg LE
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#modeling
#infection
#immunity
#antibiotic
|
|
0
|
|
Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis.
(journals.asm.org)
|
Abdelwahab MT
…
Denti P
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#modeling
#amr
#cardiotoxicity
#tb
|
|
0
|
|
Population pharmacokinetics of pyrazinamide and ethambutol in children with tuberculosis with or without HIV.
(journals.asm.org)
|
Maranchick NF
…
Kwara A
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#modeling
#hiv
#pediatrics
#tb
|
|
0
|
|
Pharmacokinetics/pharmacodynamics of KSP-1007 in combination with meropenem against carbapenemase-producing gram-negative bacteria in a neutropenic murine thigh infection model.
(journals.asm.org)
|
Takemoto K
…
Hanaki H
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#modeling
#infection
#amr
#pharmacodynamics
|
|
0
|
|
Evaluation of the clinical efficacy, safety, and permeability in pulmonary epithelial lining fluid of contezolid, a novel oxazolidinone drug, in adult patients with pneumonia.
(journals.asm.org)
|
Wu H
…
Zhang J
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#modeling
#infection
#pneumonia
#antibiotic
|
|
0
|
|
Single-ascending and multiple-ascending dose study of the pharmacokinetics, safety, and tolerability of BV100 (rifabutin for infusion) in healthy volunteers.
(journals.asm.org)
|
Kemmer C
…
Dale GE
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#infection
#amr
#bioavailability
|
|
0
|
|
Elevated hippocampal and cortical cefepime concentrations correlate with seizures in an acute kidney injury rat model.
(journals.asm.org)
|
Pais GM
…
Scheetz MH
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#modeling
#neurotoxicity
#seizures
|
|
0
|
|
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers.
(journals.asm.org)
|
Jongo S
…
Specht S
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#infection
#clinical trial
#bioavailability
#helminth
|
|
0
|
|
How to perform pharmacokinetic research of antimicrobial drugs in critically ill patients undergoing continuous renal replacement therapy: a scoping review of all relevant pharmacokinetic factors.
(linkinghub.elsevier.com)
|
Wieringa A
…
Haringman JJ
Clinical Microbiology and Infection
2026-04-01
|
#pharmacokinetics
#dosing
#amr
#renal replacement therapy
|
|
0
|
|
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in patients hospitalized with COVID-19: long-term results from the DisCoVeRy trial.
(linkinghub.elsevier.com)
|
Massonnaud CR
…
Hites M
Clinical Microbiology and Infection
2026-04-01
|
#pharmacokinetics
#infection
#immunity
#immunogenicity
|
|
0
|
|
Pharmacokinetics, safety, and tolerability of HRS-8427, a novel anti-carbapenem-resistant cephalosporin, in healthy subjects.
(journals.asm.org)
|
Yin T
…
Hu W
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#amr
#clinical trial
#antibiotic
|
|
0
|
|
Designing novel bisquinoline antimalarials from historical 4-aminoquinolines to combat drug-resistant malaria.
(journals.asm.org)
|
Handford MJ
…
Riscoe MK
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#amr
#antimalarial
#drug design
#structure-activity
|